Research Suggests GLP-1 Drugs Could Treat Addiction

Study of 600,000 U.S. veterans found glucagon-like peptide-1 drugs linked to lower substance use disorder risk.
Glucagon-like peptide-1 use reduced hospitalizations, overdoses, and deaths in those with pre-existing disorders.
Researchers recommend clinical trials for glucagon-like peptide-1 as addiction treatments.

Addiction | Medicine | Treatment

United States

5 days ago